Connect with us

News

Abu Dhabi Scientists Create Electronic Appetite Regulation Pill

The tiny device utilizes electrodes to stabilize and regulate the gut-brain axis, which can help control appetite and treat several diseases.

Published

on

abu dhabi scientists create electronic appetite regulation pill
NYUAD

A research team from NYU Abu Dhabi (NYUAD), overseen by Professor Khalil Ramadi, has created a groundbreaking “ingestible electroceutical device” known as the FLASH system. The pill-shaped device modulates the signaling pathway between the digestive tract and the central nervous system and is administered like a regular ingestible capsule tablet.

Featuring surface electrodes that deliver stimulation to the stomach’s mucosal tissues, the non-invasive device bypasses gastric acids to achieve direct electrode-to-tissue contact. The ingestible pill is powered by tiny batteries, delivering stimulation for around 20 minutes before being excreted by the body — a process that can take up to two weeks, depending on the size of the human or animal test subject.

the flash system appetite regulation pill

“FLASH is one of the first ingestible electroceuticals that can regulate precise neurohormonal circuits while avoiding the discomfort patients can experience with invasive treatments,” says Professor Khalil Ramadi, NYU Abu Dhabi.

Researchers on the FLASH project were inspired by the unique skin surface properties of the Australian Thorny Devil Lizard, whose skin can efficiently wick away surface moisture. The pill replicates this process by using grooved surface patterns and hydrophilic properties that enable it to be ingested and excreted without side effects.

Also Read: Sultan Al Neyadi Becomes The First Ever Arab To Spacewalk

During testing, scientists noted that the capsule modulated the release of the hormone ghrelin, which the body uses to stimulate hunger. Regular hormone medications have poor bioavailability in oral form, requiring an injection to administer. The FLASH system, on the other hand, can target very specific gastric-hormonal pathways through simple oral administration.

The FLASH pill shows promise against a wide range of diseases, including metabolic, gastrointestinal, and neuropsychiatric disorders. Unfortunately, the device requires further preclinical testing before being ready for the public market. However, the development team has set a goal of creating an advanced prototype for human trials within five years.

Advertisement

📢 Get Exclusive Monthly Articles, Updates & Tech Tips Right In Your Inbox!

JOIN 17K+ SUBSCRIBERS

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

News

Adobe Reveals New AI Tools That Will Wow Photoshop Novices

The company is forging ahead with its Firefly-based AI features, but some professionals have copyright concerns.

Published

on

adobe reveals new ai tools that will wow photoshop novices
Adobe

On Tuesday, April 23, Adobe announced a beta version of Photoshop boasting several fresh features aimed at helping users generate new images and manipulate existing files through text prompts. The latest generative AI additions harness the power of Adobe’s new Firefly Image 3 model.

Among the highlights of the update is the Generate Image tool, designed to generate images based on textual cues, providing users who struggle with a blank canvas a starting point to work from. Additionally, Generative Fill, an existing tool for background completion or image expansion, now incorporates a Reference Image function. The enhancement enables users to guide the tool’s output towards a specific aesthetic or theme by uploading an image as a reference.

adobe photoshop ai update firefly image 3 model

The new AI tools significantly simplify the process of translating creative ideas into images and should be useful to both Photoshop novices and seasoned pros. Firefly Image 3 now has the ability to produce astonishingly realistic images, and its enhanced understanding of text prompts is now considered industry-leading.

Despite facing scrutiny over its training data and a backlash from certain segments of the creative community, Adobe remains committed to integrating generative AI features into its entire software suite. The company continues to assert that Firefly is a safe, ethical option for commercial use and positions it as an alternative to competitors like Midjourney and Stable Diffusion —both of which have faced allegations of using copyrighted material without proper attribution or compensation.

Also Read: Lebanese Newspaper Builds AI President To Beat Political Crisis

Despite Adobe’s confidence in Firefly’s abilities, recent findings have uncovered that its training dataset includes AI-generated images sourced from Midjourney and similar platforms, raising questions about the integrity of Adobe’s claims regarding the model’s commercial viability.

While Adobe maintains that its generative AI models are trained on licensed or public domain content from Adobe Stock, enthusiast Nick St. Pierre recently pointed out on X (formerly Twitter) that “over 13% of all images on Adobe Stock are AI-generated,” and that “most of the generated content comes from Dalle and Midjourney”.

Continue Reading

#Trending